FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND OF A CALCIUM CHANNEL ANTAGONIST, METHOD FOR PREPARATION AND USETHEREOF IN THE TREATMENT OF CARDIOVASCULARILLNESSES
FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND OF A CALCIUM CHANNEL ANTAGONIST, METHOD FOR PREPARATION AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR ILLNESSES Comprises a dose of (a) enalapril or a pharmaceutically acceptable salt thereof and another dose of (b) nitren...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
10.08.2004
|
Edition | 6 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND OF A CALCIUM CHANNEL ANTAGONIST, METHOD FOR PREPARATION AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR ILLNESSES Comprises a dose of (a) enalapril or a pharmaceutically acceptable salt thereof and another dose of (b) nitrendipine or a pharmaceutically acceptable salt thereof and in that it is administered in single-dose gallenic form. The method comprises: (a) dissolving enalapril maleate in water with an inorganic salt; (b) mixing the micronized nitrendipine with a fraction of she disintegrating excipients, the wetting agent, the fragmentary diluting agent, the agglutinating agent, and the plastic diluting agent, previously sieved; (c) granulating- the products homogenized in section (b) with the solution obtained in section (a); (d) drying the granulated mass; (e) incorporating the lubricating agent, and the remaining fraction of the disintegrating excipients and homogenizing the calibrated granulate; (f) compressing the granulate. Use of said association for the manufacture of a medicament for the treatment of illnesses of the cardiovascular system. |
---|---|
AbstractList | FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND OF A CALCIUM CHANNEL ANTAGONIST, METHOD FOR PREPARATION AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR ILLNESSES Comprises a dose of (a) enalapril or a pharmaceutically acceptable salt thereof and another dose of (b) nitrendipine or a pharmaceutically acceptable salt thereof and in that it is administered in single-dose gallenic form. The method comprises: (a) dissolving enalapril maleate in water with an inorganic salt; (b) mixing the micronized nitrendipine with a fraction of she disintegrating excipients, the wetting agent, the fragmentary diluting agent, the agglutinating agent, and the plastic diluting agent, previously sieved; (c) granulating- the products homogenized in section (b) with the solution obtained in section (a); (d) drying the granulated mass; (e) incorporating the lubricating agent, and the remaining fraction of the disintegrating excipients and homogenizing the calibrated granulate; (f) compressing the granulate. Use of said association for the manufacture of a medicament for the treatment of illnesses of the cardiovascular system. |
Author | DELGADILLO DUARTE, JOAQUIN MICHETO ESCUDE, LUIS MANUEL CANOVAS SOLER, PEDRO |
Author_xml | – fullname: DELGADILLO DUARTE, JOAQUIN – fullname: MICHETO ESCUDE, LUIS MANUEL – fullname: CANOVAS SOLER, PEDRO |
BookMark | eNqFjb1OA0EMhK-Agr9nwA_ANQlFUppd352lPTta-yKgiSK0VOgSKbwdL8cG6JFG8kjzzfi6uZgPc7lqvjp-pthGNQI008DorALaAUpVz-okxtIGlS1lZ-mB5PVlJGAZ-Ildc-XiTwMCpsDTCGFAEUo1cOxV2PwBRvJBI3SV32TaYP79dO5OVjPKVDdYoFrwTOgjiZ93A-bIukULU8LMKQmZkd02l-_7j1O5-7s3zX1HHoa2HA-7cjru38pcPncBF4vl42q9Dsv_iW_Y2U1o |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | ASSOCIATION D'UNE DOSE FIXE D'UN INHIBITEUR DE L'ENZYME DE CONVERSION DE L'ANGIOTENSINE ET D'UN ANTAGONISTE DU CALCIUM, SA METHODE DE PREPARATION ET SON UTILISATION POUR LE TRAITEMENT D'AFFECTIONS CARDIOVASCULAIRES |
Edition | 6 |
ExternalDocumentID | CA2234899C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2234899C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:22:28 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2234899C3 |
Notes | Application Number: CA19982234899 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040810&DB=EPODOC&CC=CA&NR=2234899C |
ParticipantIDs | epo_espacenet_CA2234899C |
PublicationCentury | 2000 |
PublicationDate | 20040810 |
PublicationDateYYYYMMDD | 2004-08-10 |
PublicationDate_xml | – month: 08 year: 2004 text: 20040810 day: 10 |
PublicationDecade | 2000 |
PublicationYear | 2004 |
RelatedCompanies | VITA-INVEST, S.A |
RelatedCompanies_xml | – name: VITA-INVEST, S.A |
Score | 2.6052332 |
Snippet | FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND OF A CALCIUM CHANNEL ANTAGONIST, METHOD FOR PREPARATION AND USE THEREOF IN THE... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND OF A CALCIUM CHANNEL ANTAGONIST, METHOD FOR PREPARATION AND USETHEREOF IN THE TREATMENT OF CARDIOVASCULARILLNESSES |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040810&DB=EPODOC&locale=&CC=CA&NR=2234899C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDI7GQ8ANBog3OaCdqCil27hMKEvSNahNpjabBpdpXTPBZSAY4sfx53AyBlwm9RDVjQ-2XNdu_H0IXRT14qb0RyOvdBRmBnxxGzSvvSAw_mQyGTf9sR1wTmUj7oX3g_qggp4WszAOJ_TTgSNCRI0h3mfuff3618Ri7mzl-1XxDLde7iLdYrVFdRxChvNrrN3iXcUUrVHaoqQmsxZkwRBKC7qC1uxHtEXZ5_22nUl5_Z9Qom203gVd09kOqphpFW3SBe9aFW2kP7-7YfkTee-76CsSA848pnKOHRSjcM0lrCJMJFwdoTSXuZAeVbLPMy1kB3P5-JByLGQs2kKrDJ5jbgemJKGil2IaEyl5AgJNOkqKXF_ilOtYMQzlIQb_dMm8jeX29nKQ8YyDDiExLLHOONGWEMDqpSRjQvVJTnsJyUSSWEYPnu-h84hrGntgheGvwYeULMx1s49Wpy9Tc4BwoyzDa9-UEz8w4chSewalKUZQ5N76oQmbh-hgmZaj5aJjtDU_C2NBZk_Q6uztw5xCmp8VZ85D39Wnn9g |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDI5gIMaNp8Y7B7QTFV0p2y4TypJ0DbTJ1GbT4DKtaya4bBMM8eP4c7iBAZdJPUR144Mtx_rc2B9Cl9ltdpO7o5GTWwozA75oeo2a43nGnUwm44Y7LhqcY1kPe_794Hawhp6XvTB2TuiHHY4IETWGeF_Y83r-V8Ri9m7l23X2Aq9md4FuseoSHfuQ4dwqa7d4VzFFq5S2KKnKpAVZ0AdoQdfRRgMAoQVK_XbRkzL_n1CCHbTZBV3TxS5aM9M9VKZL3rU9tBX__O6G5U_kve2jz0AMOHOYSjm2oxiFLS5hFWAi4ekIpblMhXSokn2eaCE7mMunx5hjIUPRFlol8B2zOzAlERW9GNOQSMkjEGjSUVKk-grHXIeKYYCHGPzTJd9lLLu3l4KMJxx0CIlhiXXCiS4IAQq9lCRMqD5JaS8iiYiigtGDpwfoIuCahg5YYfhr8CElS3PdHKLSdDY1FYTree7XXJNPXM_4o4La08tNNgKQ23R94zeOUGWVluPVogtUDnUcDSMhH07Q9ve9mGLg7CkqLV7fzRmk_EV2br31BXUnosI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FIXED-DOSE+ASSOCIATION+OF+AN+ANGIOTENSIN-CONVERTING+ENZYME+INHIBITOR+AND+OF+A+CALCIUM+CHANNEL+ANTAGONIST%2C+METHOD+FOR+PREPARATION+AND+USETHEREOF+IN+THE+TREATMENT+OF+CARDIOVASCULARILLNESSES&rft.inventor=DELGADILLO+DUARTE%2C+JOAQUIN&rft.inventor=MICHETO+ESCUDE%2C+LUIS+MANUEL&rft.inventor=CANOVAS+SOLER%2C+PEDRO&rft.date=2004-08-10&rft.externalDBID=C&rft.externalDocID=CA2234899C |